U.S. Markets closed

Keryx Biopharmaceuticals Inc. (KERX) Worth Watching: Stock Surges 17.4%

Zacks Equity Research


Keryx Biopharmaceuticals Inc. (KERX) was a big mover last session, as the company saw its shares shoot up over 17% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $14.09 to $16.65 in the past one-month time frame, showed a pick-up yesterday at $16.54.

In the last 30 days, the company witnessed 5 downward estimate revisions and the Zacks Consensus Estimate, pegged at a loss, widened over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.

Keryx Biopharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN), with a Zacks Rank #1 (Strong Buy) along with Actelion Ltd. (ALIOF) and Cambrex Corporation. (CBM) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 DaysClick to get this free report >>






KERYX BIOPHARMACEUTICALS INC (KERX): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report


Zacks Investment Research